ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets common cancer driver in first human trial
Disease control Recruiting nowThis is an early-stage study testing a new drug called BGB-53038, which is designed to block a specific protein (KRAS) that drives the growth of many advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug, both when given alone and when …
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Virus therapy tested to fight lung cancer that stops responding to treatment
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer that has started to grow again after their first treatment with immunotherapy and chemotherapy. It compares a new two-part treatment—first a specially engineered virus given by IV, followed by standard chemotherapy…
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC